School of Medicine
Showing 5,261-5,280 of 12,891 Results
-
Katherine Kaplan
Clinical Assistant Professor, Psychiatry and Behavioral Sciences
Current Research and Scholarly InterestsDr. Kaplan's research interests span four (often overlapping) domains: (1) pathophysiologic aspects of insomnia and hypersomnia in mood disorders, including mechanisms, correlates, and sequelae of these sleep disturbances; (2) behavioral interventions for sleep disturbances in adults and adolescents; (3) circadian and psychosocial factors impacting sleep in adolescence; and (4) machine learning approaches to big data.
-
Michael J. Kaplan, MD
Professor of Otolaryngology - Head & Neck Surgery at the Stanford University Medical Center, Emeritus
Current Research and Scholarly Interests1) New therapeutic approaches for head and neck cancer, including immune stimulation possibilities (IRX-2 protocol), integration of biological modifiers, and, eventually, genetic approaches.
2) Head and neck cancer stem cells: identification, characterization, control--in conjunction with the Irv Weissman and Michael Clarke labs in the Stem Cell Institute
3) Development of innovative surgical methods at the anterior cranial base -
Robert Kaplan
Adjunct Professor, Medicine - Primary Care and Population Health
Current Research and Scholarly InterestsHealth services research
Studies on the cost and quality of health care
Health outcome measurement
Social determinants of health -
Daniel Kapp
Professor of Radiation Oncology, Emeritus
Current Research and Scholarly InterestsGynecologic malignancies; Rectal/and cancer; Breast Cancer; Hodgkin's disease; Hyperthermia; intraoperative radiation therapy; High dose rate radiation therapy; Predictive assays; Patterns of tumor spread; Health care finance.
-
Kathryn (Katie) Kapp
Postdoctoral Scholar, Radiology
Current Research and Scholarly InterestsI am interested in using mass spectrometry to study protein glycosylation, a complex post-translational modification that is known to be heavily altered in cancer and could improve early cancer detection. I am using mass spectrometry to study protein glycosylation in a variety of clinical samples and cancers, but I am particularly interested in proximal fluid samples to develop more accessible ways to obtain clinical samples to study cancer and women's health.
-
Shanthi Kappagoda
Clinical Associate Professor, Medicine - Infectious Diseases
Current Research and Scholarly InterestsCompleted a Masters degree in Health Services Research in 2012. Research focused on using network models to develop a clinical research agenda for neglected tropical diseases.
-
Cynthia Kapphahn
Clinical Professor, Pediatrics - Adolescent Medicine
Current Research and Scholarly InterestsAccess to health care services for adolescents.
Confidentiality.
Mental Health Financing.
Eating disorders. -
Mandeep Kapur, MD
Adjunct Clinical Assistant Professor, Psychiatry and Behavioral Sciences - Child & Adolescent Psychiatry and Child Development
BioDr. Kapur is a double board-certified psychiatrist. After completing her General Psychiatry residency at Tulane University, she moved back to California for her Child & Adolescent Psychiatry fellowship at Stanford University. With this specialized training, Dr. Kapur has expertise in ADHD, anxiety, depression, behavioral challenges, parent-child relational problems, among other mental health problems.
Dr. Kapur provides compassionate, evidence-based care for children, teens, young adults, and their families. She is committed to providing personalized treatment plans designed to meet each patient's unique needs and goals using a holistic, patient-centered approach to ensure the best possible outcomes. -
Spyros Karadimas, MD, PhD
Assistant Professor of Neurosurgery
BioDr. Spyridon Karadimas is a board-certified, fellowship-trained cerebrovascular neurosurgeon and physician-scientist with Stanford Health Care. He is also an assistant professor in the Department of Neurosurgery at Stanford University School of Medicine.
Dr. Karadimas offers advanced, personalized treatment for complex vascular disorders of the brain, neck, and spine in both adults and children. His expertise spans brain aneurysms, arteriovenous malformations, cavernous malformations, arteriovenous fistulas, Moyamoya disease, stroke, and carotid artery disease. Dr. Karadimas is a rare combination of surgeon, scientist, and innovator dedicated to advancing patient care and shaping the future of cerebrovascular neurosurgery.
Dr. Karadimas directs a basic and translational research program focused on the neural circuits of motor control and stroke recovery. His laboratory integrates systems neuroscience, in vivo imaging, electrophysiology, and brain-computer interface development to uncover the principles of neuroplasticity, or how the brain adapts to change. This knowledge allows him to create new ways to help people move again after a brain injury.
Dr. Karadimas has published his research as first author in peer-reviewed journals such as Nature, Nature Neuroscience and Science Translational Medicine. His work has received editorial highlight at Nature Reviews Neuroscience. He has presented to his peers at international, national, and regional meetings, including those of the American Academy of Neurological Surgery, American Association of Neurological Surgeons (AANS), European Association of Neurosurgical Societies, and World Federation of Skull Base Societies.
Dr. Karadimas is a fellow of the Royal College of Surgeons of Canada and American Association of Neurological Surgeons as well as member of the Congress of Neurological Surgeons, and the North American Skull Base Society. -
Cansu Karakas
Assistant Professor of Pathology (Clinical Pathology)
BioDr. Cansu Karakas is an Assistant Professor, with subspecialty expertise in Breast Pathology. Her academic career spans notable institutions such as MD Anderson Cancer Center and (2010–2017) and NYU (2017-2018). She is passionate about research with a focus on HER2-driven breast cancers, artificial intelligence (AI) applications in breast cancer and identifying resistance mechanisms to guide novel, personalized therapeutic strategies in breast cancer.